KRAS and lung cancer: Our group has previously shown that COPD-type airway inflammation promotes lung cancer in a K-ras mutant mouse model, this was found to be associated with the activation of NF-ĸB, thus suggesting a role for this pathway in linking COPD to lung cancer (8).